{"version":"1.0","provider_name":"Sickle Cell Disease Association of America Inc.","provider_url":"https:\/\/www.sicklecelldisease.org","author_name":"admin","author_url":"https:\/\/www.sicklecelldisease.org\/author\/admin\/","title":"GBT Launches ACCEL Grants Program to Improve Access to Care for People with Sickle Cell Disease - Sickle Cell Disease Association of America Inc.","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"oqnBUO6aj9\"><a href=\"https:\/\/www.sicklecelldisease.org\/2019\/02\/22\/gbt-launches-accel-grants-program-to-improve-access-to-care-for-people-with-sickle-cell-disease\/\">GBT Launches ACCEL Grants Program to Improve Access to Care for People with Sickle Cell Disease<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.sicklecelldisease.org\/2019\/02\/22\/gbt-launches-accel-grants-program-to-improve-access-to-care-for-people-with-sickle-cell-disease\/embed\/#?secret=oqnBUO6aj9\" width=\"600\" height=\"338\" title=\"&#8220;GBT Launches ACCEL Grants Program to Improve Access to Care for People with Sickle Cell Disease&#8221; &#8212; Sickle Cell Disease Association of America Inc.\" data-secret=\"oqnBUO6aj9\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/www.sicklecelldisease.org\/wp-content\/uploads\/2019\/03\/GBT-inthenews-header.png","thumbnail_width":800,"thumbnail_height":250,"description":"\u2014The Access to Excellent Care for Sickle Cell Patients Pilot Program (ACCEL) Supports Novel Projects Aimed at Improving Access to High-Quality Healthcare for People with Sickle Cell Disease\u2014 \u2014GBT Will Fund Proposals With the Highest Potential to Impact Patient Care\u2014 SOUTH SAN FRANCISCO, Calif.\u00a0\u2013\u00a0Feb. 19, 2019 \u2013\u00a0Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced [&hellip;]"}